deltatrials
Completed OBSERVATIONAL NCT00639418

A Study to Describe Pediatric Influenza Vaccine Coverage

An Observational Study to Describe Pediatric Influenza Vaccine Coverage Among Pediatricians in the United States

Sponsor: MedImmune LLC

Conditions Healthy
Updated 9 times since 2017 Last updated: Sep 12, 2014 Started: Aug 31, 2007 Primary completion: Mar 31, 2011 Completion: Jun 30, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Healthy, this trial is completed. The trial is conducted by MedImmune LLC and has accumulated 9 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Apr 2018 · 15 months · monthly snapshotCompleted~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jan 2023 — Jul 2024 [monthly]

    Completed

  5. Dec 2022 — Jan 2023 [monthly]

    Completed

Show 4 earlier versions
  1. Jan 2021 — Dec 2022 [monthly]

    Completed

  2. Jun 2018 — Jan 2021 [monthly]

    Completed

  3. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: PHASE4None

  4. Jan 2017 — Apr 2018 [monthly]

    Completed PHASE4

    First recorded

Aug 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • MedImmune LLC
Data source: MedImmune LLC

For direct contact, visit the study record on ClinicalTrials.gov .